2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension

Clinical Hypertension
Hae-Young LeeShung Chull Chae

Abstract

The standardized techniques of blood pressure (BP) measurement in the clinic are emphasized and it is recommended to replace the mercury sphygmomanometer by a non-mercury sphygmomanometer. Out-of-office BP measurement using home BP monitoring (HBPM) or ambulatory BP monitoring (ABPM) and even automated office BP (AOBP) are recommended to correctly measure the patient's genuine BP. Hypertension (HTN) treatment should be individualized based on cardiovascular (CV) risk and the level of BP. Based on the recent clinical study data proving benefits of intensive BP lowering in the high risk patients, the revised guideline recommends the more intensive BP lowering in high risk patients including the elderly population. Lifestyle modifications, mostly low salt diet and weight reduction, are strongly recommended in the population with elevated BP and prehypertension and all hypertensive patients. In patients with BP higher than 160/100 mmHg or more than 20/10 mmHg above the target BP, two drugs can be prescribed in combination to maximize the antihypertensive effect and to achieve rapid BP control. Especially, single pill combination drugs have multiple benefits, including maximizing reduction of BP, minimizing adverse effects, increasi...Continue Reading

References

May 21, 1992·The New England Journal of Medicine·J E MansonC H Hennekens
Dec 1, 1989·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·A ZanchettiP Sleight
Dec 12, 1985·The New England Journal of Medicine·L RosenbergS Shapiro
Oct 8, 1994·BMJ : British Medical Journal·R DollI Sutherland
May 13, 1998·Circulation·N J Brown, D E Vaughan
Feb 19, 1999·Lancet·D M Lloyd-JonesD Levy
May 20, 1999·Hypertension·J Profant, J E Dimsdale
Jan 4, 2001·The New England Journal of Medicine·F M SacksUNKNOWN DASH-Sodium Collaborative Research Group
Jul 14, 2001·The American Journal of Clinical Nutrition·E ObarzanekUNKNOWN DASH Research Group
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Paul K WheltonUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Jun 5, 2003·Journal of Hypertension·UNKNOWN European Society of Hypertension-European Society of Cardiology Guidelines Committee
Sep 19, 2003·Lancet·K M Fox, UNKNOWN EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
Oct 25, 2003·Stroke; a Journal of Cerebral Circulation·Parveen RashidPhilip Bath
Nov 12, 2003·Hypertension·Feng J He, Graham A MacGregor
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 15, 2004·BMJ : British Medical Journal·Francesco P CappuccioAnna Donald
Aug 6, 2004·The New England Journal of Medicine·Biff F Palmer
Sep 8, 2004·Lancet·Philip A Poole-WilsonUNKNOWN Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators
Nov 9, 2004·The New England Journal of Medicine·Eugene BraunwaldUNKNOWN PEACE Trial Investigators
Nov 13, 2004·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN GEMINI Investigators
Dec 28, 2004·The American Journal of Cardiology·Franz H MesserliCarl J Pepine
Mar 16, 2006·The New England Journal of Medicine·Stevo JuliusUNKNOWN Trial of Preventing Hypertension (TROPHY) Study Investigators
Apr 4, 2006·International Journal of Epidemiology·UNKNOWN Asia Pacific Cohort Studies Collaboration
Apr 6, 2006·Annals of Internal Medicine·Patricia J ElmerUNKNOWN PREMIER Collaborative Research Group
May 11, 2006·Journal of Hypertension·Hisatomi ArimaUNKNOWN PROGRESS Collaborative Group

❮ Previous
Next ❯

Citations

Sep 10, 2019·The Journal of Clinical Hypertension·Weizhong Zhang
Oct 2, 2019·International Journal of Clinical Practice·Jing LiuYong Huo
Oct 30, 2019·The Journal of Clinical Hypertension·Sung-Bum LeeDong-Hyuk Jung
Feb 25, 2020·The Journal of Clinical Hypertension·Kazuomi Kario
May 20, 2020·The Journal of Clinical Hypertension·Bingqing ZhouChunyu Zeng
Aug 11, 2020·The Journal of Clinical Hypertension·Hack-Lyoung KimMyung-A Kim
Dec 20, 2019·Korean Circulation Journal·Hae Young Lee
Nov 20, 2019·The Journal of Clinical Hypertension·Yook-Chin ChiaJi-Guang Wang
Apr 11, 2020·International Journal of Environmental Research and Public Health·Hon Lon TamKin Cheung
Jan 8, 2020·Clinical Hypertension·Gyu Chul Oh, Hyun-Jai Cho
May 8, 2020·Clinical Hypertension·Jing Liu
Apr 14, 2020·Korean Circulation Journal·Jinho Shin, Myeong Chan Cho
Dec 7, 2019·Clinical Hypertension·Ravi Tejraj MehtaShruti Dharmadhikari
Nov 7, 2019·The Journal of Clinical Hypertension·Jinho ShinJi-Guang Wang
Oct 13, 2020·The Journal of Clinical Hypertension·Ji-Guang WangYutaka Imai
Nov 30, 2020·The Journal of Clinical Hypertension·Tsung-Ying TsaiChen-Huan Chen
Dec 5, 2020·The Journal of Clinical Hypertension·Hao-Chih ChangKazuomi Kario
Dec 16, 2020·The Journal of Clinical Hypertension·Kazuomi KarioJi-Guang Wang
Dec 22, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hokyou LeeHyeon Chang Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
X-ray

Software Mentioned

SPRINT

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.